Psma imaging prostate cancer diagnostic imaging. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Neoplastic Cells, Circulating Stromal Cells

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases35

Neoplasms Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Adenocarcinoma Disease Progression Neoplasm Metastasis Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Lung Neoplasms Carcinoma Neoplasm Recurrence, Local Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Pancreatic Neoplasms Prostatitis Urinary Bladder Neoplasms Neovascularization, Pathologic Colorectal Neoplasms Disease Models, Animal Uterine Cervical Neoplasms Carcinoma, Squamous Cell Ganglion Cysts Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Rectal Neoplasms Erectile Dysfunction Radiation Injuries

Chemicals and Drugs70

Glutamate Carboxypeptidase II Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds Antigens, Surface Antineoplastic Agents Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists RNA, Messenger Anilides Metribolone Dihydrotestosterone Finasteride Cancer Vaccines Antigens, Neoplasm RNA, Small Interfering Flutamide Anticarcinogenic Agents Taxoids DNA, Neoplasm 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Testosterone Congeners Antineoplastic Agents, Phytogenic Testosterone Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Antibodies, Monoclonal Azasteroids Nitriles Phenylthiohydantoin Proto-Oncogene Proteins c-akt RNA, Neoplasm Racemases and Epimerases Radiopharmaceuticals MicroRNAs Tumor Suppressor Protein p53 Transcription Factors Carboxypeptidases Cholestenone 5 alpha-Reductase Tumor Suppressor Proteins Estramustine Leuprolide Receptor, erbB-2 Goserelin Glutathione S-Transferase pi Tissue Kallikreins DNA-Binding Proteins Receptors, Estrogen DNA Primers Proto-Oncogene Proteins Enzyme Inhibitors Kallikreins Prostatic Secretory Proteins Proto-Oncogene Proteins c-bcl-2 Oncogene Proteins, Fusion Androgen-Binding Protein Steroid 17-alpha-Hydroxylase Paclitaxel Biological Markers Insulin-Like Growth Factor Binding Protein 3 Ki-67 Antigen Reagent Kits, Diagnostic Carotenoids Receptor, Epidermal Growth Factor Nuclear Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Prostatectomy Orchiectomy Early Detection of Cancer Sensitivity and Specificity Neoplasm Staging Neoplasm Grading Prognosis Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Risk Factors Neoplasm Transplantation Digital Rectal Examination Immunohistochemistry Prospective Studies Biopsy Retrospective Studies Case-Control Studies Blotting, Western Transplantation, Heterologous Gene Expression Profiling Follow-Up Studies Predictive Value of Tests Biopsy, Needle Risk Reproducibility of Results Transurethral Resection of Prostate Risk Assessment Survival Rate Survival Analysis Treatment Outcome Incidence Cohort Studies Odds Ratio Polymerase Chain Reaction Tumor Burden Diagnostic Errors Diagnostic Imaging Oligonucleotide Array Sequence Analysis Transfection Brachytherapy Tissue Array Analysis ROC Curve Combined Modality Therapy Multivariate Analysis Disease-Free Survival Registries Castration SEER Program Antineoplastic Combined Chemotherapy Protocols Logistic Models Diagnostic Tests, Routine Questionnaires Radiotherapy Mass Screening Kaplan-Meier Estimate Diagnostic Techniques and Procedures Molecular Targeted Therapy Nomograms Radiotherapy Dosage Drug Screening Assays, Antitumor Radiotherapy, Conformal Immunoenzyme Techniques Confidence Intervals Models, Biological Positron-Emission Tomography Clinical Trials as Topic Tomography, X-Ray Computed Disease Models, Animal Gene Knockdown Techniques Flow Cytometry Immunotherapy In Situ Hybridization, Fluorescence Enzyme-Linked Immunosorbent Assay Drug Delivery Systems Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Real-Time Polymerase Chain Reaction Magnetic Resonance Imaging Chemotherapy, Adjuvant Reagent Kits, Diagnostic Proportional Hazards Models Genetic Therapy

Psychiatry and Psychology2

Smoking Erectile Dysfunction

Phenomena and Processes44

Gene Expression Regulation, Neoplastic Sensitivity and Specificity Cell Proliferation Genetic Predisposition to Disease Apoptosis Risk Signal Transduction Cell Growth Processes Drug Resistance, Neoplasm Genotype Cell Survival Down-Regulation Cell Division Odds Ratio Time Factors Transfection Gene Fusion Cell Movement DNA Methylation Up-Regulation Promoter Regions, Genetic Mutation Polymorphism, Genetic Cell Cycle Dose-Response Relationship, Drug Base Sequence Nomograms Gene Silencing Genes, Tumor Suppressor Chromosomes, Human, Pair 8 RNA Interference Gene Expression Polymorphism, Single Nucleotide Phosphorylation Diet Alleles Transcription, Genetic Phenotype Genes, Neoplasm Tissue Distribution Germ-Line Mutation Algorithms Protein Binding Drug Synergism

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Registries SEER Program Questionnaires Molecular Sequence Data Base Sequence Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Algorithms

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care35

Patient Navigation Sensitivity and Specificity Risk Factors Prospective Studies Watchful Waiting Retrospective Studies Case-Control Studies Follow-Up Studies Predictive Value of Tests Risk Reproducibility of Results Risk Assessment Survival Rate Survival Analysis Treatment Outcome Incidence Cohort Studies Odds Ratio Diagnostic Errors Age Factors ROC Curve Multivariate Analysis Disease-Free Survival Registries SEER Program National Cancer Institute (U.S.)Logistic Models Questionnaires Mass Screening Kaplan-Meier Estimate Nomograms Confidence Intervals Clinical Trials as Topic Proportional Hazards Models Radiation Injuries

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Patient Navigation Prostate Neoplasms Prostatic Neoplasms Glutamate Carboxypeptidase II Prostate-Specific Antigen Cell Line, Tumor Receptors, Androgen Androgens Androgen Antagonists Prostatectomy Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Tumor Markers, Biological Early Detection of Cancer Mice, Nude Adenocarcinoma Disease Progression Neoplasm Metastasis Sensitivity and Specificity Prostatic Intraepithelial Neoplasia Tosyl Compounds Bone Neoplasms Neoplasm Staging Neoplasm Invasiveness Neoplasm Grading Antigens, Surface Tumor Cells, Cultured Prognosis Cell Proliferation Antineoplastic Agents Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Genetic Predisposition to Disease Antineoplastic Agents, Hormonal Apoptosis Risk Factors Neoplasm Proteins Androgen Receptor Antagonists Neoplasm Transplantation RNA, Messenger Digital Rectal Examination Immunohistochemistry Anilides Breast Neoplasms Prospective Studies Watchful Waiting Biopsy Retrospective Studies Metribolone Dihydrotestosterone Case-Control Studies Blotting, Western Transplantation, Heterologous Finasteride Gene Expression Profiling Follow-Up Studies Lung Neoplasms Predictive Value of Tests Carcinoma Biopsy, Needle Risk Cancer Vaccines Reproducibility of Results Signal Transduction Transurethral Resection of Prostate Risk Assessment Neoplasm Recurrence, Local United States Mice, SCID Ovarian Neoplasms Antigens, Neoplasm Cell Growth Processes Survival Rate Drug Resistance, Neoplasm Survival Analysis Prostatic Neoplasms, Castration-Resistant Genotype Treatment Outcome RNA, Small Interfering Flutamide Cell Survival Anticarcinogenic Agents Down-Regulation Incidence Cohort Studies Taxoids Cell Division Colonic Neoplasms Odds Ratio Polymerase Chain Reaction Tumor Burden Time Factors DNA, Neoplasm Diagnostic Errors 5-alpha Reductase Inhibitors Diagnostic Imaging Oligonucleotide Array Sequence Analysis

No FAQ available that match "psma imaging prostate cancer diagnostic imaging"